Sotalol hydrochloride is an essential class II and III antiarrhythmic agent prescribed for life-threatening ventricular arrhythmias and for maintaining normal sinus rhythm in patients with atrial fibrillation or atrial flutter. The API is classified under ATC code C07AA07, covering non‑selective beta‑blocking agents. With a robust pipeline of generics, a growing prevalence of cardiovascular diseases, and evolving supply chain dynamics, understanding the global buyer landscape is essential for any pharmaceutical business. This guide consolidates market intelligence, identifies key buyers across regions, and offers actionable procurement strategies. 1. Global Market Overview The global sotalol market has been experiencing steady expansion. The sotalol hydrochloride market was valued at approximately USD 700 million in…